Bronchoscopic Hand Instrument Market Size, Share, & COVID-19 Impact Analysis | Global | 2023-2029 | MedCore
- Year: 2023
- Scope: 10 Years
- Region: Global
- Pages: 7
- Published Date: 02/09/2023
- Type: MedCore
Overall, the global bronchoscopic hand instrument market was valued at $15.3 million in 2022. This is expected to increase over the forecast period at a CAGR of 1.0% to reach $16.3 million.
The full report suite on the global market for bronchoscopic hand instruments focuses on these instruments only and does not include the market’s extended set.
MARKET DATA INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2029, and Historical Data to 2019
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL BRONCHOSCOPIC HAND INSTRUMENT MARKET INSIGHTS
The emerging trend within this market is the rise of single-use bronchoscopes. They have been existing in the market since 2009; however, their guaranteed sterility feature has only been recently noticed by healthcare systems around the world due to COVID-19. It is expected that this segment of the market will experience high growth rates over the forecast period.
GLOBAL BRONCHOSCOPIC HAND INSTRUMENT MARKET SHARE INSIGHTS
The Global bronchoscopic hand instrument market was controlled by Karl Storz, LYMOL Medical, and Richard Wolf.
In 2022, Karl Storz was the leading competitor in the bronchoscopic hand instrument market. The company carries an extensive line of hand instruments for various surgical procedures. Karl Storz will often bundle its hand instruments to provide a central distributor for its clients since these instruments are used with rigid bronchoscopy. This strategy has worked well to make Karl Storz one of the leading competitors in the bronchoscopic hand instrument market.
MARKET SEGMENTATION SUMMARY
- Bronchoscope Hand Instrument Market – MedCore
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2022 |
| Forecast Period | 2023-2029 |
| Historical Data | 2019-2022 |
| Quantitative Data | Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices |
| Qualitative Data | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.
Read more about iData’s 9-Step Research Methodology |
WHY CHOOSE IDATA?
- Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
Table of Contents
| Bronchoscopic Hand Instrument Market |
| 16.1 Introduction |
| 16.2 Market Analysis and Forecast |
| 16.3 Drivers and Limiters |
| 16.3.1 Market Drivers |
| 16.3.2 Market Limiters |
| 16.4 Competitive Market Share Analysis |
Companies Included:
| Karl Storz |
| LYMOL Medical |
| Richard Wolf |
| Teleflex |
| Integra LifeSciences |
| Others include: Ace Medical Devices, Medicta Instruments, Mednova Medical Technology, Novatech, Peak Surgicals, Thempson, Zhejiang Geyi Medical Instrument, etc. |
List of Charts
| Chart 16‑1: Bronchoscopic Hand Instrument Market, U.S., 2019 – 2029 |
| Chart 16‑2: Leading Competitors, Bronchoscopic Hand Instrument Market, U.S., 2022 |
List of Figures
| Figure 16‑1: Bronchoscopic Hand Instrument Market, U.S., 2019 – 2029 |
| Figure 16‑2: Leading Competitors, Bronchoscopic Hand Instrument Market, U.S., 2022 |
iData’s 9-Step Research Methodology
Our reports follow an in-depth 9-step methodology which focuses on the following research systems:- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.
Explore Options
| Report Summary | FREE |
Bronchoscopic Hand Instrument Market Size, Share, & COVID-19 Impact Analysis | Global | 2023-2029 | MedCore
$4,995 – $8,995
The full report suite on the global market for bronchoscopic hand instruments focuses on these instruments only and does not include the market’s extended set.
- 2023
- 10 Years
- Global
- 02/09/2023
- 7
- MedCore
Related Reports
